Physician burnout rates have dropped slightly since the last study in 2021, but still remain a concern, affecting quality of patient care and work-life integration. Women physicians are more likely to experience burnout than men, while doctors in certain specialties like emergency medicine face heightened risk.
A new study published in Nature found that the shingles vaccine may lower dementia risk by 20%, with researchers analyzing health records of over 280,000 older adults in Wales. The vaccine was shown to reduce the occurrence of shingles by 37% and is considered a promising preventive intervention for dementia.
A Stanford Medicine study reveals glucose plays a crucial role in tissue regeneration by binding to proteins that control gene expression. Researchers found that glucose levels increase significantly as cells differentiate, supporting the growth of specialized cells in various tissues.
A Stanford Medicine study demonstrates how an AI algorithm can enable doctors to make better clinical decisions for sick newborns. The algorithm predicts which nutrients preemies need and in what quantities, reducing medical errors and saving time.
A new gel impregnated with molecule T-5224 blocks key signaling pathway in scar tissue formation, reducing adhesions by nearly 300% in mice and minipigs. The gel is easy to apply and release the molecule over a period of two weeks.
Researchers develop a 'colocatome' to study the interactions between cancer cells and their surrounding non-cancerous cells, revealing how these interactions impact tumor growth and treatment resistance. The study aims to provide insights into universal rules of tumor behavior and guide the design of more effective treatments.
A newly discovered peptide called BRP has been found to rival semaglutide (Ozempic) in suppressing appetite and reducing body weight. Unlike Ozempic, BRP acts through a separate metabolic pathway, activating different neurons in the brain, which may offer a more targeted approach to body weight reduction.
Researchers at Stanford Medicine have devised a way to mine the immune system's internal database to diagnose diseases such as diabetes and COVID-19. The machine-learning based technique, called Mal-ID, uses B and T cell receptor sequences and structures to identify individuals with specific diseases.
A large-scale screen of single nucleotide variants has identified 380 variants controlling cancer-associated genes. These variants regulate biological pathways such as DNA repair, energy production, and cell microenvironment interaction. The findings suggest new therapeutic targets for preventing or stopping cancer growth.
A new Stanford Medicine-led study found that 59% of kids who die in mass shootings were at the hands of a family member. The research highlights the need to protect children from firearm injuries and domestic violence, emphasizing that homes may be more dangerous than schools.
A new blood test developed at Stanford Medicine has shown to accurately diagnose invasive mold disease in most cases, replacing invasive procedures. The test detects genetic material from mold in the bloodstream, allowing for faster diagnosis and treatment, which has been linked to improved patient outcomes.
Researchers at Stanford Medicine classified breast cancers into three main groups based on structural variations in their DNA, including repeats of oncogenes and small DNA circles. Understanding these variations could aid physicians in making decisions and point to new targeted therapeutic interventions.
A Stanford Medicine study found that AI-powered chatbots can effectively answer nuanced clinical questions and improve physician performance. The research showed that chatbots outperformed doctors in certain scenarios, particularly when combined with human expertise, suggesting a potential future direction for AI-assisted medical decis...
A new study from Stanford Medicine found that certain short-chain fatty acids produced by gut microbiome digestion have anti-cancer actions. The researchers discovered direct epigenetic changes at specific genes regulating cell proliferation and differentiation, potentially leading to cancer disruption.
Researchers developed an AI model, MUSK, that incorporates visual and language-based information to predict cancer outcomes and identify patients who benefit from immunotherapy. The model achieved 75% accuracy in predicting disease-specific survival, outperforming standard methods that were correct 64% of the time.
A new AI-based algorithm can parse three of the four most common Type 2 diabetes subtypes using data from continuous blood glucose monitors. The technology could help individuals take preventative measures by identifying prediabetes warning signs and adjusting dietary or exercise habits accordingly.
A Stanford Medicine-led study has discovered a molecular signature in the blood that can predict how long an individual's vaccine immunity will last. The signature, found in platelet RNA molecules, is associated with megakaryocyte activation in the bone marrow and can forecast longer-lasting antibody responses to various vaccines.
Researchers identified a molecular signature in blood that predicts vaccine response durability, pointing to megakaryocytes as key players. The discovery may lead to personalized vaccines and better understanding of vaccine science.
A Stanford Medicine study found that AI can help researchers quickly evaluate large amounts of medical data, identifying trends and patterns. The tool was trained on notes from 1,201 children with ADHD, allowing researchers to pinpoint gaps in follow-up care and identify tactics to improve ADHD management.
Researchers have developed a way to make the seasonal influenza vaccine more effective by targeting all four subtypes of the flu virus. The method works by tricking the immune system into producing antibodies that can bind to multiple types of viruses, reducing the risk of severe illness.
Researchers domesticated a bacterial species that lives on human skin, discovering it triggers an immune response similar to vaccinations. The team engineered the bacteria to produce a protein that induces a powerful immune reaction, creating a living, topical vaccine.
A large multisite study found that two common antiseizure medications, lamotrigine and levetiracetam, are safe to use during pregnancy, with no statistically significant differences in cognitive and psychosocial outcomes at age 6. The study confirms these drugs offer a safe alternative to older antiseizure medications like valproate.
Stanford Medicine researchers used a new gene-screening method to identify the CA12 gene as a key factor in doxorubicin-induced heart cell damage. They found that a drug called indisulam may be able to prevent this toxicity, and have tested it in mice with promising results.
Scientists create a molecule that tethers BCL6 to CDK9, switching on apoptosis genes in cancer cells. The approach aims to eliminate cancer cells with high specificity and avoid treatment resistance.
A new class of neurological diseases called TRiCopathies has been identified, linked to mutations in a protein complex that helps fold proteins correctly. The study found that patients with intellectual disabilities and seizures have defects in the TRiC complex, which affects brain development and function.
A new AI-powered tool can predict the activity of thousands of genes within tumor cells based on standard microscopy images of biopsy samples. The tool showed a high correlation with real gene activity data, particularly for certain cancer types.
A study by Stanford Medicine researchers has identified a critical link between the composition of antibodies and the severity of influenza infection. The discovery highlights the importance of a specific sugar molecule on antibodies in determining whether an individual becomes mildly ill or severely ill from a flu infection.
In a groundbreaking trial, CAR-T cell therapy has shown promising results in shrinking brain tumors and restoring neurologic function in children with deadly brain cancer. The study found significant clinical benefits in nine out of 11 participants, including four who experienced complete tumor regression.
Researchers found ecDNA prevalence in nearly 15,000 human cancers and associated it with metastasis, poorer survival. EcDNA plays a critical role in cancer initiation and evolution through novel inheritance mechanisms.
A recent study by Stanford Medicine suggests that new blood-based colon cancer screening tests are effective for people who shun traditional methods. However, if too many switch to the new tests, colorectal cancer death rates may rise due to reduced detection of early cancers and precancerous polyps.
A new 10-question screening tool can identify patients at high risk of developing post-traumatic stress disorder, depression or anxiety two months after emergency care. The Hospital Mental Health Risk Screen has been shown to correctly predict mental health diagnoses in 79% of patients.
A new study by Stanford Medicine found that upgrading emergency departments to be more prepared for pediatric care could save children's lives and reduce costs. The research team analyzed data from hundreds of hospitals in 11 states and found that doing so would cut deaths of pediatric emergency patients by almost half.
A study published in JAMA Network Open found that children with high or severe levels of sleep disturbance are more than twice as likely to develop suicidal thoughts and behaviors during the next two years. Frequent nightmares were particularly associated with an increased risk.
A Stanford Medicine study suggests that targeting the glucose transporter GLUT4 protein may help reactivate neural stem cells in older brains, leading to increased neuron production. The research also identified other genetic pathways associated with neural stem cell activation, offering potential avenues for developing new therapies.
A study led by Stanford Medicine scientists reveals that inversions in DNA can occur within a single gene, challenging the central dogma of biology. This discovery has potential applications in synthetic biology and disease regulation.
A new study found that cognitive behavioral therapy can alter brain circuitry in adults with depression and obesity, leading to improved problem-solving skills and reduced symptoms. After just two months of therapy, patients showed adaptive changes in their brain circuits, which predicted long-term therapy success.
A new study published in Annals of Internal Medicine found that low-impact yoga programs can significantly reduce episodes of urinary incontinence in older women, with benefits comparable to those of medications. The study also showed that stretching and strengthening exercises had similar effects.
For some older adults with kidney failure, waiting to start dialysis when their eGFR falls below a certain threshold can prolong life by roughly one week. However, this approach also means spending more time in hospitals or care facilities.
A Stanford Medicine study reveals significant biomolecular changes in the mid-40s and early 60s, affecting cardiovascular disease, immune function, and other age-related health risks. The researchers analyzed thousands of molecules and microbiomes across 108 participants, tracking rapid fluctuations in molecular abundance.
A Stanford Medicine study found that premature babies who received more skin-to-skin care had stronger neurodevelopmental performance at 1 year. The intervention was simple: a parent holding the baby on their chest with only a diaper on.
A Stanford Medicine-led study found that the US method for ranking children on the waitlist for heart transplants does not consistently rank patients based on their medical need. The current system prioritizes geographic location, immune compatibility, and body size over medical urgency.
A new study by Stanford Medicine researchers found that Black Americans are more likely to die from causes related to air pollution compared to other racial and ethnic groups. The study attributed this disparity to a combination of factors, including socioeconomic disadvantage, education level, and geographic location.
A new CAR-T cell therapy targeting CD22 has shown significant improvement in patients with large B-cell lymphoma, with over half experiencing a complete response. The therapy, which targets a different protein on the surface of cancer cells, has improved outcomes for patients who have failed previous treatments.
Researchers discover a novel compound that can work alongside naloxone to reverse opioid overdoses, reducing withdrawal symptoms and enhancing naloxone's life-saving effects. The new compound, known as compound 368, binds next to naloxone on opioid receptors, holding it in place and slowing its natural degradation.
A class of existing high blood pressure drugs appears to reduce adults' risk of developing epilepsy, with a 20-30% lower risk found among those taking angiotensin receptor blockers. Researchers hope these findings lead to randomized clinical trials to confirm the association.
Researchers at Stanford Medicine have identified six biological subtypes, or biotypes, of depression using brain imaging and machine learning. These subtypes are associated with different responses to antidepressant treatments, offering new hope for personalized medicine approaches in mental health.
A large Stanford Medicine study has found that the risk of secondary blood cancers after CAR-T cell therapy is low, around 6.5% in three years. The therapy did not introduce lymphoma into patients with pre-existing cancer cells, which were already present at low levels.
A 15-day Paxlovid regimen was found to be safe for extended treatment, but did not show a clear reduction in select symptoms of long COVID. The trial enrolled 155 participants who had been infected with SARS-CoV-2 and reported moderate to severe long-COVID symptoms.
Research by Stanford Medicine scientists reveals that adaptive myelination in the brain can contribute to drug addiction, with a single dose of morphine triggering maladaptive myelination and reinforcing drug-seeking behavior.
A Stanford Medicine study found that inherited gene sequences predict breast cancer type and mortality. The research challenges the dogma of random mutations, instead highlighting the role of germline genome factors in tumor development.